Lincoln Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 183.08 | 181.47 | 170.60 |
| Operating Expense | 162.42 | 142.73 | 137.94 |
| Net Profit | 11.63 | 28.60 | 19.98 |
| Net Profit Margin | 6.35% | 15.76% | 11.71% |
| Earning Per Share | 5.81 | 14.28 | 9.98 |
| EBIDTA | 24.26 | 38.63 | 32.78 |
| Effective Tax Rate | 42.01% | 15.51% | 27.40% |
Particulars
Mar 2026
Revenue183.08
Operating Expense162.42
Net Profit11.63
Net Profit Margin6.35
Earning Per Share5.81
EBIDTA24.26
Effective Tax Rate42.01
